Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTBK1 | Q5TCY1 | 6/20 | 0.32 |
| ▸ | TTBK2 | Q6IQ55 | 3/20 | 0.32 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26619428 | 0.88 | PIK3CB (0.31) | TTBK1TTBK2MAP3K14BRD4PIK3CB | |
| SCHEMBL26596996 | 0.84 | PIK3CB (0.34) | BRD4PIK3CBKDM4EPRKCI | |
| SCHEMBL31219317 | 0.78 | CDK1 (0.36) | PIK3CBKDM4EMEN1KMT2APRKCI | |
| SCHEMBL20731183 | 0.78 | CDK1 (0.36) | PIK3CBKDM4EMEN1KMT2APRKCI | |
| SCHEMBL23685967 | 0.77 | MAP3K14 (0.39) | TTBK1TTBK2MAP3K14 | |
| SCHEMBL16978038 | 0.75 | MKNK2 (0.38) | TTBK1MEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL26605339 | 0.74 | TTBK1 (0.31) | TTBK1TTBK2MAP3K14 | |
| SCHEMBL24597088 | 0.73 | ATM (0.44) | KDM4EMEN1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL26638261 | 0.73 | TTBK1 (0.44) | TTBK1TTBK2MAP3K14BRD4PIK3CB | |
| SCHEMBL31219354 | 0.72 | GLO1 (0.40) | PIK3CBPRKCI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | TTBK1 3394/4885TTBK2 3128/4885MAP3K14 4108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.